PLRX PEER ANALYSIS

Pliant Therapeutics Inc — metric-by-metric comparison with peers and the industry median

PLRXPliant Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

PLRXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	PLRX	RTALB	MSB	TLX	Ind. Median
P/E	—	4.89	—	—	17.91
P/B	0.44●	0.61	—	6.37	3.51
EV/EBITDA	—	74.61●	—	120.14	14.82
P/S	—	6.67	31.61	3.24●	10.89

Financial Health
Metric	PLRX	RTALB	MSB	TLX	Ind. Median
Current Ratio	16.89●	1.21	—	1.43	5.90
Debt/Equity	17.4%	1.2%●	—	112.3%	10.9%
NetDebt/EBITDA	1.32	0.90●	—	13.13	1.15

Profitability
Metric	PLRX	RTALB	MSB	TLX	Ind. Median
Net Margin	—	136.3%●	-115.3%	-0.9%	-125.7%
ROE	-53.6%	15.1%●	-11.3%	-1.8%	-47.5%
ROA	-41.4%	13.1%●	-8.6%	-0.7%	-35.8%
EBITDA Margin	—	9.0%●	-76.6%	3.0%	-105.8%

Growth + Dividend
Metric	PLRX	RTALB	MSB	TLX	Ind. Median
Rev. Growth	-100.0%	24.0%	410.4%●	56.3%	5.1%
NI Growth	—	134.0%	—	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	PLRX	MCRB	PEPG	ACRV	VRCA	PMVP	Ind. Median
P/E	—	—	—	—	—	—	17.91
P/B	0.44●	2.80	0.55	0.70	4.07	0.74	3.51
EV/EBITDA	—	—	—	—	—	—	14.82
P/S	—	64.66	—	—	1.76●	—	10.89

Financial Health
Metric	PLRX	MCRB	PEPG	ACRV	VRCA	PMVP	Ind. Median
Current Ratio	16.89●	1.65	14.98	8.98	2.02	11.14	5.90
Debt/Equity	17.4%	303.8%	12.4%	2.5%	9.0%	0.3%●	10.9%
NetDebt/EBITDA	1.32	-1.21●	1.52	1.16	1.69	1.19	1.15

Profitability
Metric	PLRX	MCRB	PEPG	ACRV	VRCA	PMVP	Ind. Median
Net Margin	—	-4,088.8%	—	—	-48.0%●	—	-125.7%
ROE	-53.6%●	-121.9%	-68.4%	-60.4%	—	-63.2%	-47.5%
ROA	-41.4%	-33.3%●	-54.4%	-54.4%	-44.0%	-58.6%	-35.8%
EBITDA Margin	—	-3,650.0%	—	—	-30.6%●	—	-105.8%

Growth + Dividend
Metric	PLRX	MCRB	PEPG	ACRV	VRCA	PMVP	Ind. Median
Rev. Growth	-100.0%	-80.7%	-100.0%	-100.0%	417.6%●	—	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PLRX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.